Our new Marketplace Crash Course is here to help. Sign-up for free, learn at your own pace.
The CEO of the Serum Institute of India said American raw materials are running out due to Biden administration policy.
Pfizer and others are collaborating to accelerate production. Johnson & Johnson and Novavax may receive FDA approval soon.